These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6139196)

  • 21. [Use of beta-blockers in the acute phase of myocardial infarction].
    Marcillac-Desruennes M; Weber S; Degeorges M
    Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):519-23. PubMed ID: 6152138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 23. [Which therapy in the acute stage of myocardial infarct is in position to prolong survival?].
    Colombo ML; Specchia G
    Minerva Cardioangiol; 1988 Oct; 36(10):473-81. PubMed ID: 2906411
    [No Abstract]   [Full Text] [Related]  

  • 24. [Secondary prevention of myocardial infarct using beta-blockers].
    Vacheron A
    Bull Acad Natl Med; 1985 Mar; 169(3):369-73. PubMed ID: 2864119
    [No Abstract]   [Full Text] [Related]  

  • 25. Heart rate is a simplistic marker of mortality in acute myocardial infarction.
    Futterman LG; Lemberg L
    Am J Crit Care; 1999 May; 8(3):197-9. PubMed ID: 10228662
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-blockers after myocardial infarction.
    Med Lett Drugs Ther; 1982 Apr; 24(608):43-4. PubMed ID: 6123072
    [No Abstract]   [Full Text] [Related]  

  • 27. [Beta blockers after myocardial infarct: patients with low and high risk factors benefit equally].
    Ritzmann P
    Praxis (Bern 1994); 1999 Jun; 88(24):1098. PubMed ID: 10420804
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
    Tomov I
    Vutr Boles; 1984; 23(3):16-25. PubMed ID: 6147044
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-blockers for heart failure: is slowing of heart rate essential?
    Tendera M
    Eur Heart J; 1999 Apr; 20(8):560-1. PubMed ID: 10337539
    [No Abstract]   [Full Text] [Related]  

  • 30. [Usefulness of beta-blockers in the post-acute myocardial infarct patient].
    Shapiro M
    Arch Inst Cardiol Mex; 1984; 54(2):117-20. PubMed ID: 6204603
    [No Abstract]   [Full Text] [Related]  

  • 31. [The use of beta-adrenoblockaders during and after an acute myocardial infarct].
    Preobrazhenskiĭ DV; Fomichev VI; Afanas'ev AIa; Buravlev MB
    Ter Arkh; 1994; 66(8):84-8. PubMed ID: 7985167
    [No Abstract]   [Full Text] [Related]  

  • 32. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
    Lechat P
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686
    [No Abstract]   [Full Text] [Related]  

  • 35. [Beta receptor blocker in acute myocardial infarct and in secondary prevention].
    Werdan K
    Internist (Berl); 1991 May; 32(5):300-1. PubMed ID: 1678386
    [No Abstract]   [Full Text] [Related]  

  • 36. [Beta blockers following acute myocardial infarct?].
    Kjøller E; Rasmussen C; Reckling JC
    Ugeskr Laeger; 1987 Dec; 149(50):3397-9. PubMed ID: 2893484
    [No Abstract]   [Full Text] [Related]  

  • 37. Göteborg Metoprolol Trial: clinical observations.
    Herlitz J; Hartford M; Pennert K; Waagstein F; Waldenström A; Wedel H; Wilhelmsson C; Hjalmarson A
    Am J Cardiol; 1984 Jun; 53(13):37D-45D. PubMed ID: 6731328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secondary prevention after an acute myocardial infarct. Adrenergic beta-blockers, angiotensin-converting enzyme inhibitors and statins for everyone?].
    Morais J
    Rev Port Cardiol; 2000 Jan; 19(1):99-105. PubMed ID: 10731795
    [No Abstract]   [Full Text] [Related]  

  • 39. [Secondary prevention of myocardial infarction with beta-blockers: for how many?].
    Rahav G; Eliakim R; Dror N; Shalev O
    Harefuah; 1987 Feb; 112(3):116-8. PubMed ID: 2886409
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of beta-blockers in the secondary prevention of acute myocardial infarcts. Status and recomendations].
    Jurgensen HJ
    Ugeskr Laeger; 1984 Mar; 146(12):863-8. PubMed ID: 6144204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.